 |
|
|
| |
Alteration of Hepatic OATP Activity Does Not Alter the Pharmacodynamic Effect of GS-0976, a Liver-Targeted ACC Inhibitor, on De Novo Lipogenesis
|
| |
| |
Reported by Jules Levin
AASLD 2018, November 9-13 San Francisco, CA
Brian J. Kirby, Justin D. Lutz, Kimberly L. Garrison, Adrianne Vesterdahl, Mun Sang Yue, Ann Ran-Ran Qin, Robert P. Myers, Brian P. Kearney, Anita Mathias - Gilead Sciences, Inc., Foster City, CA
|
| |
|
|
|
|
|
